1-196950993-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_005666.4(CFHR2):c.395G>A(p.Arg132Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,612,732 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0067 ( 13 hom., cov: 33)
Exomes 𝑓: 0.00066 ( 12 hom. )
Consequence
CFHR2
NM_005666.4 missense
NM_005666.4 missense
Scores
18
Clinical Significance
Conservation
PhyloP100: -1.24
Genes affected
CFHR2 (HGNC:4890): (complement factor H related 2) This gene belongs to a family of complement factor H-related genes (CFHR), which are clustered together with complement factor H gene on chromosome 1, and are involved in regulation of complement. Mutations in CFHR genes have been associated with dense deposit disease and atypical haemolytic-uraemic syndrome. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-196950993-G-A is Benign according to our data. Variant chr1-196950993-G-A is described in ClinVar as [Benign]. Clinvar id is 789953.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00669 (1009/150934) while in subpopulation AFR AF= 0.0236 (968/41042). AF 95% confidence interval is 0.0224. There are 13 homozygotes in gnomad4. There are 489 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR2 | NM_005666.4 | c.395G>A | p.Arg132Gln | missense_variant | 3/5 | ENST00000367415.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR2 | ENST00000367415.8 | c.395G>A | p.Arg132Gln | missense_variant | 3/5 | 1 | NM_005666.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00666 AC: 1005AN: 150812Hom.: 13 Cov.: 33
GnomAD3 genomes
AF:
AC:
1005
AN:
150812
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00162 AC: 407AN: 251314Hom.: 4 AF XY: 0.00114 AC XY: 155AN XY: 135810
GnomAD3 exomes
AF:
AC:
407
AN:
251314
Hom.:
AF XY:
AC XY:
155
AN XY:
135810
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000664 AC: 971AN: 1461798Hom.: 12 Cov.: 31 AF XY: 0.000567 AC XY: 412AN XY: 727190
GnomAD4 exome
AF:
AC:
971
AN:
1461798
Hom.:
Cov.:
31
AF XY:
AC XY:
412
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00669 AC: 1009AN: 150934Hom.: 13 Cov.: 33 AF XY: 0.00662 AC XY: 489AN XY: 73818
GnomAD4 genome
AF:
AC:
1009
AN:
150934
Hom.:
Cov.:
33
AF XY:
AC XY:
489
AN XY:
73818
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
104
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
254
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.;.;.
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
.;N;.;.;.
REVEL
Benign
Sift
Benign
.;T;.;.;.
Sift4G
Benign
.;T;.;T;.
Polyphen
0.97
.;D;.;.;.
Vest4
0.12, 0.18
MVP
MPC
0.022
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 35
Find out detailed SpliceAI scores and Pangolin per-transcript scores at